Literature DB >> 24410539

Diagnosis of cow's milk allergy in children: determining the gold standard?

Christophe Dupont1.   

Abstract

Cow's milk protein allergy (CMPA) affect many organs, from mouth to gut, with, immediate and delayed reactions, including infantile colic, food protein induced enterocolitis syndrome, enteropathy, eosinophilic disorders, among which infantile proctocolitis, and "dysmotility" disturbances, gastro-esophageal reflux and constipation. Diagnosis follows usual steps, careful history taking and medical examination, before starting an elimination diet, for diagnosis and treatment. Beyond, laboratory tests may help, but definitive conclusion will arise from the oral food challenge. The double-blind-placebo-controlled-food challenge, the "gold standard", is needed in clinical research. The food challenge includes the progressive at-home reintroduction of milk, all the more needed since most cases of CMPA in infants are delayed: in clinical practice, diagnosing CMPA is more than saying if the child reacts to cow's milk. One has to define the syndrome the child is suffering from, the risk implied, the best replacement formula. When tolerance develops, a second diagnostic procedure allows seeing if the child has outgrown his disease and, if not, what is the expected outcome and which type of food is best adapted: small amounts of milk, or transformed forms, such as baked milk. Primary care practice is adapted to non-IgE mediated CMPA. When CMPA is part of multiple food allergies or of an eosinophilic disorder, referral centers will perform multiple allergy testing, endoscopic procedures and complex dietary guidance.

Entities:  

Mesh:

Year:  2014        PMID: 24410539     DOI: 10.1586/1744666X.2014.874946

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  7 in total

1.  A thickened amino-acid formula in infants with cow's milk allergy failing to respond to protein hydrolysate formulas: a randomized double-blind trial.

Authors:  Christophe Dupont; Nicolas Kalach; Pascale Soulaines; Elena Bradatan; Alain Lachaux; François Payot; Frédéric de Blay; Lydie Guénard-Bilbault; Riad Hatahet; Sandra Mulier
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

2.  Anxiety-like behavior and intestinal microbiota changes as strain-and sex-dependent sequelae of mild food allergy in mouse models of cow's milk allergy.

Authors:  Nicholas A Smith; Danielle L Germundson; Pan Gao; Junguk Hur; Angela M Floden; Kumi Nagamoto-Combs
Journal:  Brain Behav Immun       Date:  2021-03-09       Impact factor: 19.227

3.  Tolerance and growth in children with cow's milk allergy fed a thickened extensively hydrolyzed casein-based formula.

Authors:  Christophe Dupont; Elena Bradatan; Pascale Soulaines; Rita Nocerino; Roberto Berni-Canani
Journal:  BMC Pediatr       Date:  2016-07-18       Impact factor: 2.125

4.  A specific synbiotic-containing amino acid-based formula in dietary management of cow's milk allergy: a randomized controlled trial.

Authors:  Adam T Fox; Harm Wopereis; Marleen T J Van Ampting; Manon M Oude Nijhuis; Assad M Butt; Diego G Peroni; Yvan Vandenplas; David C A Candy; Neil Shah; Christina E West; Johan Garssen; Lucien F Harthoorn; Jan Knol; Louise J Michaelis
Journal:  Clin Transl Allergy       Date:  2019-01-15       Impact factor: 5.871

5.  Antigenicity and Safety Evaluation of Lactiplantibacillus plantarum 7-2 Screened to Reduce α-Casein Antigen.

Authors:  Guangqing Mu; Zhao Zhang; Jiayi Wang; Shujuan Jiang; Hongxin Wang; Yunpeng Xu; Xinling Li; Lei Chi; Yue Li; Yanfeng Tuo; Xuemei Zhu
Journal:  Foods       Date:  2021-12-29

6.  Powder milk: a user-friendly and safe product for heated-milk food challenge?

Authors:  Sabrine Cherkaoui; Philippe Bégin; Louis Paradis; Jean Paradis; Anne Des Roches
Journal:  Allergy Asthma Clin Immunol       Date:  2015-12-23       Impact factor: 3.406

7.  A synbiotic-containing amino-acid-based formula improves gut microbiota in non-IgE-mediated allergic infants.

Authors:  David C A Candy; Marleen T J Van Ampting; Manon M Oude Nijhuis; Harm Wopereis; Assad M Butt; Diego G Peroni; Yvan Vandenplas; Adam T Fox; Neil Shah; Christina E West; Johan Garssen; Lucien F Harthoorn; Jan Knol; Louise J Michaelis
Journal:  Pediatr Res       Date:  2017-12-06       Impact factor: 3.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.